Intramyocardial dissecting hematoma: A systematic review and pooled analysis of available literature

Reihaneh Zavar1, Azam Soleimani2, Marzieh Tajmirriahi3

  • 1Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

ARYA Atherosclerosis
|August 21, 2024
PubMed

Insights

Older patients with intramyocardial dissecting hematoma (IDH) face a higher mortality risk. Diagnostic tools like angiography and cardiac MRI improve outcomes, while pericardial effusion worsens prognosis for IDH patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pathology

Background:

  • Intramyocardial dissecting hematoma (IDH) is a rare cardiac condition.
  • Understanding its demographics, clinical features, management, and prognosis is crucial.

Purpose of the Study:

  • To systematically review and pool data on intramyocardial dissecting hematoma.
  • To analyze demographic characteristics, clinical findings, management, and prognosis.

Main Methods:

  • Systematic search of PubMed, Scopus, and Web of Science databases up to February 2023.
  • Pooled analysis of case reports and case series data.
  • Statistical significance set at P < 0.05 using SPSS software.

Main Results:

  • 77 patients with IDH were analyzed; mean age 58.7 years, 22.1% women.
  • Increased mortality risk observed in older patients (OR=1.05, P=0.014).
  • Angiography (OR=0.25, P=0.010) and cardiac MRI (OR=0.19, P=0.004) reduced mortality risk.
  • Pericardial effusion diagnosis significantly increased mortality risk (OR=3.92, P=0.017).

Conclusions:

  • Older age is associated with a poor prognosis in IDH.
  • Angiography and cardiac MRI improve patient prognosis.
  • Pericardial effusion is a significant risk factor for mortality in IDH patients.
Abstract